+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neutralisation of endogenous IL-18 activity is a disease-modifying therapy in the collagen-induced model of arthritis



Neutralisation of endogenous IL-18 activity is a disease-modifying therapy in the collagen-induced model of arthritis



Journal of Leukocyte Biology Suppl.: 92




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035384085

Download citation: RISBibTeXText


Related references

Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. Journal of Clinical Investigation 108(12): 1825-1832, 2001

Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies. Arthritis and Rheumatism 44(5): 1215-1224, 2001

A8.9 Neutralisation of miR-155 ameliorates collagen-induced arthritis. Annals of the Rheumatic Diseases 74(Suppl 1): A84-A85, 2015

CXCL13 neutralisation influences the severity of collagen induced arthritis. Inflammation Research 52(Suppl. 2): S 145, 2003

THU0046Abatacept Decreases Disease Activity in the Absence of CD4+ T-Cells in the Collagen Induced Arthritis Model. Annals of the Rheumatic Diseases 74(Suppl 2): 208.3-209, 2015

Abatacept decreases disease activity in a absence of CD4(+) T cells in a collagen-induced arthritis model. Arthritis Research and Therapy 17: 220, 2015

Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis. Arthritis and Rheumatism 52(6): 1929-1940, 2005

CD97 neutralisation increases resistance to collagen-induced arthritis in mice. Arthritis Research and Therapy 8(5): R155, 2006

Treatment of collagen induced arthritis by proteolytic enzymes: immunomodulatory and disease modifying effects. Journal of Rheumatology 28(9): 2049-2059, 2001

Nimesulide improves the symptomatic and disease modifying effects of leflunomide in collagen induced arthritis. Plos one 9(11): E111843, 2014

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis and Rheumatism 58(10): 2968-2980, 2008

Nimesulide improves the disease modifying anti-rheumatic profile of methotrexate in mice with collagen-induced arthritis. European Journal of Pharmacology 644(1-3): 245-250, 2010

Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats. Journal of Pharmacology and Experimental Therapeutics 326(2): 532-545, 2008

Combined Collagen-Induced Arthritis and Organic Dust-Induced Airway Inflammation to Model Inflammatory Lung Disease in Rheumatoid Arthritis. Journal of Bone and Mineral Research 34(9): 1733-1743, 2019

Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis. Arthritis and Rheumatism 52(12): 3761-3771, 2005